Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 6/20 | 0.48 |
| ▸ | F3 | P13726 | 18/20 | 0.47 |
| ▸ | F2 | P00734 | 11/20 | 0.47 |
| ▸ | F7 | P08709 | 5/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8506821 | 0.94 | F10 (0.52) | F10F3F2F7 | |
| Trifluoroacetic Acid SCHEMBL7152732 | 0.92 | F10 (0.47) | F10F3F2F7 | |
| Trifluoroacetic Acid SCHEMBL7154799 | 0.90 | F10 (0.49) | F10F3F2F7 | |
| Trifluoroacetic Acid SCHEMBL7153773 | 0.89 | F10 (0.48) | F10F3F2F7 | |
| Trifluoroacetic Acid SCHEMBL6300737 | 0.88 | BRD4 (0.45) | F10F3F2F7 | |
| Trifluoroacetic Acid SCHEMBL7153927 | 0.88 | F2 (0.49) | F10F3F2F7 | |
| SCHEMBL6300848 | 0.87 | F10 (0.47) | F10F3F2F7 | |
| Trifluoroacetic Acid SCHEMBL7158701 | 0.87 | F2 (0.53) | F10F3F2F7 | |
| Trifluoroacetic Acid SCHEMBL7150780 | 0.86 | PRSS1 (0.55) | F10F3F2F7 | |
| Trifluoroacetic Acid SCHEMBL7153982 | 0.84 | F10 (0.47) | F10F3F2F7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6916837-B2 | Amidino derivatives and anticoagulants and thrombosis therapeutic agents containing them | EISAI CO., LTD. (JP) | 2005-07-12 | — | — | US | disclosed |
| US-20030181766-A1 | Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2003-09-25 | — | — | US | disclosed |
| EP-1312602-A1 | Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them | Eisai Co., Ltd. (JP) | 2003-05-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181766-A1 | Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them | F2, SERPINC1, F12 | F10 34/4885F3 56/4885F2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.